相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck
Jong Woo Lee et al.
CLINICAL CANCER RESEARCH (2019)
Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene
Xueqian Gong et al.
CANCER DISCOVERY (2019)
Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
Changjie Wu et al.
NATURE COMMUNICATIONS (2018)
ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data
Shinya Oki et al.
EMBO REPORTS (2018)
AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer
Ahmed S. K. Al-Khafaji et al.
ONCOLOGY LETTERS (2017)
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
Vural Tagal et al.
NATURE COMMUNICATIONS (2017)
Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling
Dong-Yao Wang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression
Tzu-Po Chuang et al.
ONCOTARGET (2016)
Aurora-A mediated histone H3 phosphorylation of threonine 118 controls condensin I and cohesin occupancy in mitosis
Candice L. Wike et al.
ELIFE (2016)
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
Norman Ertych et al.
NATURE CELL BIOLOGY (2014)
Applying Synthetic Lethality for the Selective Targeting of Cancer
Donal P. McLornan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents
William T. Harkcom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma
Yi-Ling Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
J. A. C. M. Goos et al.
BRITISH JOURNAL OF CANCER (2013)
A new method for high-resolution imaging of Ku foci to decipher mechanisms of DNA double-strand break repair
Sebastien Britton et al.
JOURNAL OF CELL BIOLOGY (2013)
Emerging roles of RB family: New defense mechanisms against tumor progression
Paola Indovina et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1
Victoria C. Silva et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Functional impact of Aurora A-mediated phosphorylation of HP1γ at serine 83 during cell cycle progression
Adrienne Grzenda et al.
EPIGENETICS & CHROMATIN (2013)
Oncogene-Induced Mitotic Stress: p53 and pRb Get Mad Too
Marcos Malumbres
CANCER CELL (2011)
Mad2 Is a Critical Mediator of the Chromosome Instability Observed upon Rb and p53 Pathway Inhibition
Juan-Manuel Schvartzman et al.
CANCER CELL (2011)
Aurora A Is a Repressed Effector Target of the Chromatin Remodeling Protein INI1/hSNF5 Required for Rhabdoid Tumor Cell Survival
SeungJae Lee et al.
CANCER RESEARCH (2011)
Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation
Marco Lo Iacono et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo
Huifang Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Microtubule-Disrupting Chemotherapeutics Result in Enhanced Proteasome-Mediated Degradation and Disappearance of Tubulin in Neural Cells
Lyn M. Huff et al.
CANCER RESEARCH (2010)
Uncovering new substrates for Aurora A kinase
Teresa Sardon et al.
EMBO REPORTS (2010)
The microtubule-targeting agent T0070907 induces proteasomal degradation of tubulin
Gianni Harris et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
Aurora-A kinase: a novel target of cellular immunotherapy for leukemia
Toshiki Ochi et al.
BLOOD (2009)
Regulation of Microtubule Dynamic Instability in Vitro by Differentially Phosphorylated Stathmin
Tapas Manna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Stathmin Regulates Centrosomal Nucleation of Microtubules and Tubulin Dimer/Polymer Partitioning
Danielle N. Ringhoff et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients
Charles N. Landen et al.
CLINICAL CANCER RESEARCH (2007)
MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy
Kara Hoar et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Roles of aurora kinases in mitosis and tumorigenesis
Jingyan Fu et al.
MOLECULAR CANCER RESEARCH (2007)
FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane
K Nishida et al.
JOURNAL OF CELL BIOLOGY (2005)
Molecular mechanisms of E2F-dependent activation and pRB-mediated repression
MV Frolov et al.
JOURNAL OF CELL SCIENCE (2004)
Overexpression and amplification of Aurora-A in hepatocellular carcinoma
YM Jeng et al.
CLINICAL CANCER RESEARCH (2004)
E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M
RG Polzin et al.
GENE (2004)
The role of stathmin in the regulation of the cell cycle
CI Rubin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Genomic targets of the human c-Myc protein
PC Fernandez et al.
GENES & DEVELOPMENT (2003)
The effect of stathmin phosphorylation on microtubule assembly depends on tubulin critical concentration
P Amayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans
E Hannak et al.
JOURNAL OF CELL BIOLOGY (2001)
Perspectives for cancer therapies with cdk2 inhibitors
S Wadler
DRUG RESISTANCE UPDATES (2001)
分享论文
